Anti-arthritic and anti- inflammatory effects of extract and fractions of Malva parviflora in a mono- arthritis model induced with kaolin/carrageenan.
Gabriela Belen Martínez-HernándezGabriela Vargas-VillaEnrique Jiménez-FerrerMaribel Patricia García-AguilarAlejandro ZamilpaRubén Román-RamosManasés González-CortazarMargarita Avilés-FloresMacrina Fuentes-MataMaribel Herrera-RuizPublished in: Naunyn-Schmiedeberg's archives of pharmacology (2020)
Malva parviflora is used as food in the gastronomy of some regions of Mexico and, also, in Mexican traditional medicine for inflammation-related conditions like rheumatoid arthritis. The objective of this work was to evaluate its antiarthritic activity in a mice model. In ICR, female mice were tested the dichloromethane extract (MpD) and fractions MpF4 (extracted with a dichoromethane:methanol system) and MpFphy (a precipitate by acetone:methanol) by using the mono-arthritis with kaolin/carrageenan model. During the treatment, joint inflammation was measured daily, and hyperalgesia was measured using the hot plate test. The treatments diminished both joint inflammation and pain. At the end of the evaluation, the left joint and spleen were extracted for determination of pro- and anti-inflammatory cytokines. The results showed that the MpD, MpF4, and MpFphy treatments modulated the concentration of these proteins. Specifically, MpFphy at 1.0 mg/kg increased IL-4 and IL-10 and decreased IL-17, IL-1β, and TNF-α. GC-MS analysis showed that MpF4 contained a mixture of a total of nine compounds, three of them newly reported for the species. The studies confirmed the presence of five sterols in the MpFphy fraction, including stigmasterol and β-sitosterol. These results confirm the anti-rheumatoid and anti-inflammatory activities of a fraction rich in sterols from Malva parviflora. Graphical abstract.
Keyphrases
- anti inflammatory
- rheumatoid arthritis
- oxidative stress
- diabetic rats
- neuropathic pain
- disease activity
- high fat diet induced
- carbon dioxide
- climate change
- physical activity
- spinal cord injury
- interstitial lung disease
- adipose tissue
- high glucose
- rheumatoid arthritis patients
- insulin resistance
- mass spectrometry
- systemic lupus erythematosus
- drug induced
- idiopathic pulmonary fibrosis
- case control